Julia K. Rotow

机构：Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute · ORCID：0000-0003-4547-2960

发表论文 229 篇 · 总被引 4219 次 · h-index 23

代表论文

• Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry (2025 · JCO Precision Oncology · 被引 2)
• LBA13 Enozertinib (ORIC-114), a highly selective, brain penetrant EGFR and HER2 inhibitor, in EGFR Exon 20 mutant NSCLC: Randomized dose optimization and CNS activity (2025 · Annals of Oncology · 被引 1)
• Data from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib (2026)
• Supplementary Tables1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib (2026)
• Supplementary Figures1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib (2026)
• Supplementary Data1 from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco (2026)